Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Category: CEO

Intel CEO Takes 25% Pay Cut. It’s a Sign of the Times.
The move suggest companies could start to implement more than just job cuts to get costs down.

ICR Hosts FAT Brands CEO Andy Wiederhorn on the Welcome to the Arena Podcast
NEW YORK–( BUSINESS WIRE )–ICR, a leading strategic communications and advisory firm, is pleased to announce that Andy Wiederhorn, President and CEO of FAT (Fresh.

Qualigen Therapeutics Chief Executive Officer Michael Poirier Provides Letter to Stockholders
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing

Unicredit CEO says the bank’s transformation is not yet done
Unicredit CEO Andrea Orcel tells CNBC how the lender beat 2022 targets despite the unwinding of its Russia business and other macro headwinds. The Italian

Saviynt Raises $205M; Founder Rejoins as CEO, Appoints Seasoned President to Accelerate its Leadership in Identity Management
LOS ANGELES–( BUSINESS WIRE )–Saviynt, a leading provider of intelligent identity and access governance solutions, today announced that it has closed $205 million in growth

Reviva Pharmaceuticals to Present at the 2023 BIO CEO and Investor Conference
Cupertino, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that

Optinose Announces CEO Transition and Business Update
Ramy Mahmoud, MD, MPH appointed CEO and to the Board of Directors Ramy Mahmoud, MD, MPH appointed CEO and to the Board of Directors

SHRM President and CEO Johnny C. Taylor, Jr. to Keynote First Advantage Collaborate Conference
Thought Leader to Address Key Topics Impacting Today’s Workforces Thought Leader to Address Key Topics Impacting Today’s Workforces

Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference
MALVERN, Pa., Jan. 31, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing

Tesla’s Stock Price Is Up 20 Percent. Is Elon Musk To Thank?
A strong Q4 performance gave Tesla its most profitable year on record, with 1.8m Tesla units in 2023 predicted to be in production